E. M. Beraha, E. Salemink, A. E. Goudriaan, A. Bakker, D. De-jong et al., Efficacy and safety of high-dose baclofen for the treatment of alcohol dependence: a multicentre, randomised, double blind controlled trial, Eur. Neuropsychopharmacol. J. Eur. Coll. Neuropsychopharmacol, vol.26, 2016.

D. W. Boulton, P. Arnaud, and C. L. Devane, Pharmacokinetics and pharmacodynamics of methadone enantiomers after a single oral dose of racemate, Clin. Pharmacol. Ther, vol.70, pp.48-57, 2001.

B. Rolland, F. Paille, C. Gillet, A. Rigaud, R. Moirand et al., Pharmacotherapy for Alcohol Dependence: The 2015Recom-mendations of the French Alcohol Society, Issued in Partnership with theEuropean Federation of Addiction Societies, CNS Neurosci Ther, vol.22, issue.1, pp.25-37, 2016.

A. Marsot, B. Imbert, J. Alvarez, S. Grassin-delyle, I. Jaquet et al., High variability in the exposure of baclofen in alcohol-dependent patients, Alcohol. Clin. Exp. Res, vol.38, pp.316-321, 2014.

C. A. Müller, O. Geisel, P. Pelz, V. Higl, J. Krüger et al., Highdose baclofen for the treatment of alcohol dependence (BACLAD study): a randomized, placebo controlled trial. Eur. Neuropsychopharmacol, J. Eur. Coll. Neuropsychopharmacol, vol.25, pp.1167-1177, 2015.

M. Costa, I. Paca, A. Université, F. Marseille, L. Benjamin-rolland-service-universitaire-d'addictologie et al.,